Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)

Top Cited Papers
Open Access
Abstract
Atrial fibrillation (AF) affects approximately 5 million people worldwide and is associated with an increased risk of stroke.1 The primary treatment of patients with paroxysmal AF is the relief of symptoms measured by reducing the frequency and recurrence of episodes.1 Atrial fibrillation considerably impairs quality of life, independently of the severity of the disease.1-3 Maintenance of sinus rhythm is usually the goal for patients with paroxysmal AF because it reportedly improves quality of life.4,5

This publication has 30 references indexed in Scilit: